Literature DB >> 27429913

Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Jeffrey M C Lau1, Jie Zheng2.   

Abstract

The hybrid positron emission tomography/magnetic resonance (PET/MR) is a new imaging tool that has garnered immense research interest for its potentials to assist clinical investigations. PET/MR combines the quantitative measurement of PET with dynamic functional and anatomic assessment of MR and can deliver a robust clinical examination. Currently, simultaneous cardiovascular PET/MR imaging remains in the pre-clinical research stage, and most institutions have not adopted a clinical PET/MR clinical imaging service. Nevertheless, PET/MR examination has unique promises in several areas of cardiovascular medicine, and in recent years more and more research publications have become available to lend us insight into its utility in cardiovascular imaging. Here we review the existing literature on simultaneous cardiovascular PET/MR imaging, with an emphasis on organizing the current literature into disease-specific discussions. These areas include coronary artery disease (CAD), carotid atherosclerosis, various infiltrative, inflammatory and hereditary heart diseases, myocarditis, vasculitis, and cardiac mass assessment. The purpose of this review is to provide an overview of the current understanding of cardiovascular PET/MR clinical imaging, in a disease-specific manner, from a clinician's perspective. Potential limitations of simultaneous PET/MR, such as cost effectiveness, artifacts, contraindications, and radiation exposure, are briefly discussed.

Entities:  

Keywords:  PET-MR; Positron emission tomography/magnetic resonance (PET/MR); cardiac; cardiovascular; coronary artery disease (CAD); review

Year:  2016        PMID: 27429913      PMCID: PMC4929286          DOI: 10.21037/qims.2016.06.07

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  54 in total

1.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

Review 2.  Cardiovascular PET/MRI: Challenges and Opportunities.

Authors:  Richard LaForest; Pamela K Woodard; Robert J Gropler
Journal:  Cardiol Clin       Date:  2016-02       Impact factor: 2.213

Review 3.  Underlying pathology of stroke of unknown cause (cryptogenic stroke).

Authors:  Pierre Amarenco
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

Review 4.  Myocardial sarcoidosis.

Authors:  O P Sharma; A Maheshwari; K Thaker
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

5.  Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.

Authors:  Michael Marnane; Aine Merwick; Orla C Sheehan; Niamh Hannon; Paul Foran; Tim Grant; Eamon Dolan; Joan Moroney; Sean Murphy; Killian O'Rourke; Kevin O'Malley; Martin O'Donohoe; Ciaran McDonnell; Imelda Noone; Mary Barry; Morgan Crowe; Eoin Kavanagh; Martin O'Connell; Peter J Kelly
Journal:  Ann Neurol       Date:  2012-03-29       Impact factor: 10.422

6.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

7.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

8.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

9.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

10.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983

View more
  1 in total

1.  Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging.

Authors:  Yuanbo Feng; Bianca Hemmeryckx; Liesbeth Frederix; Marleen Lox; Jun Wu; Ward Heggermont; Hua Rong Lu; David Gallacher; Raymond Oyen; H Roger Lijnen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2018-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.